SDF-1 DC1/DC2 and Tumor Angiogenesis
Abstract
Ovarian carcinomas have a poor prognosis, often associated with multifocal intraperitoneal dissemination accompanied by intense neovascularization. To examine tumor angiogenesis in the tumor microenvironment, we studied malignant ascites of patients with untreated ovarian carcinoma. We observed high numbers of plasmacytoid dendritic cells (PDC) and significant stromal derived factor (cxcL-12/sDF)-l in their malignant ascites attracting PDC into the tumor environment. We now show that tumor associated PDC induced angiogenesis in vivo. By contrast, myeloid dendritic cells (MDC) were absent from malignant ascites. MDC derived in vitro suppressed angiogenesis in vivo. Thus, the tumor may attract PDC to augment angiogenesis, while excluding MDC to prevent angiogenesis inhibition. Although dendritic cells have long been known to affect tumor immunity, these data also implicate them in tumor neoangiogenesis.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 2004
- Accession Number
- ADA425742
Entities
People
- Weiping Zou
Organizations
- Tulane University of Louisiana